[High-dose pemetrexed in combination with temolozomide for the treatment of newly diagnosed primary central nervous system lymphoma]
- PMID: 27033765
- PMCID: PMC7342948
- DOI: 10.3760/cma.j.issn.0253-2727.2016.03.014
[High-dose pemetrexed in combination with temolozomide for the treatment of newly diagnosed primary central nervous system lymphoma]
Similar articles
-
Pemetrexed for primary central nervous system lymphoma in the elderly.Clin Transl Oncol. 2016 Feb;18(2):138-43. doi: 10.1007/s12094-015-1345-4. Epub 2015 Jul 14. Clin Transl Oncol. 2016. PMID: 26169215
-
Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial.Oncologist. 2020 Sep;25(9):747-e1273. doi: 10.1634/theoncologist.2020-0489. Epub 2020 Jul 1. Oncologist. 2020. PMID: 32520407 Free PMC article. Clinical Trial.
-
Pemetrexed for Recurrent Primary Central Nervous System Lymphoma in the Elderly: Results of a Retrospective Study.J Healthc Eng. 2022 Mar 29;2022:8963547. doi: 10.1155/2022/8963547. eCollection 2022. J Healthc Eng. 2022. Retraction in: J Healthc Eng. 2023 Sep 20;2023:9847489. doi: 10.1155/2023/9847489. PMID: 35392141 Free PMC article. Retracted.
-
The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma.Cancers (Basel). 2021 Apr 16;13(8):1920. doi: 10.3390/cancers13081920. Cancers (Basel). 2021. PMID: 33923396 Free PMC article. Review.
-
Radiotherapy for newly diagnosed primary central nervous system lymphoma: role and perspective.Rep Pract Oncol Radiother. 2023 Jun 26;28(2):271-285. doi: 10.5603/RPOR.a2023.0028. eCollection 2023. Rep Pract Oncol Radiother. 2023. PMID: 37456704 Free PMC article. Review.
References
-
- 潘 隆盛, 许 百男, 周 定标, et al. 原发性中枢神经系统淋巴瘤的诊治[J] 中华神经外科杂志. 2008;24(11):648–652. doi: 10.3321/j.issn:1001-2346.2008.11.004. - DOI